EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Preexisting Humoral Immunity Against Seasonal Coronaviruses Enhances Antibody Responses on SARS-CoV-2 Vaccination

Etsuro Nanishi iD, Matthew Hwang iD, Ana Citlali Márquez, Walter Byrne, Maria-Rosa La Neve, Alice Litosh, Jasmik S Saini, Kimberly Thompson, Nicole Wisener, Makiko Nanishi, Julia E M Upton, Aaron Campigotto und 3 weitere

Open Forum Infectious Diseases · 28.04.2026 · 13 (5)

DOI: 10.1093/ofid/ofag232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 14.05.2026. Verfasst von Etsuro Nanishi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Hospital for Sick Children Foundation, University of Toronto, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High homology and cross-reactive immune responses have been reported between SARS-CoV-2 and seasonal human coronaviruses (HCoVs). However, the impact of preexisting immunity against seasonal HCoVs on SARS-CoV-2 vaccination is undetermined.

Methods

We conducted a cross-sectional study involving pediatric and adult participants between August 2020 and August 2023. IgG titers against SARS-CoV-2 and seasonal HCoV-229E, -HKU1, -NL63, and -OC43 were quantified by electrochemiluminescent immunoassay. A paired analysis was performed in a subset of participants with samples collected before and after SARS-CoV-2 vaccination.

Results

A total of 1804 participants were enrolled (median age, 44 years; range, 2–95). IgG titers against HCoV-229E, -HKU1, and -OC43 increased during early childhood. Among participants without prior SARS-CoV-2 infection who were SARS-CoV-2-vaccinated, anti-spike IgG titers against SARS-CoV-2 positively correlated with titers against HCoV-OC43, -HKU1, and -NL63 (Spearman r = 0.40, 0.26, and 0.12, respectively; P < .0001, P < .0001, and P = .0002). In paired analysis, participants with high baseline HCoV-HKU1 and -OC43 IgG titers developed higher postvaccination anti-SARS-CoV-2 spike IgG responses than those with low baseline titers (geometric mean [arbitrary units/mL]: 111 384 vs 54 610 and 113 279 vs 50 099; P = .03 and .015). Multivariable linear regression analyses demonstrated that baseline HCoV-HKU1 and -OC43 IgG titers remained independently associated with postvaccination anti-SARS-CoV-2 spike IgG levels (β = 110 592 and 108 855; 95% CI, 17 922–203 262 and 12 013–205 697; P = .020 and .028).

Conclusions

Higher baseline immunity to HCoV-HKU1 and -OC43 was associated with stronger SARS-CoV-2 vaccine–induced antibody responses. These findings suggest that preexisting immunity against seasonal betacoronaviruses may enhance humoral immune response to SARS-CoV-2 vaccination.

Schlagwörter

Stichwörter der Autor:innen

SARS-CoV-2betacoronavirusespreexisting immunityseasonal coronavirusesvaccine

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Public Health Laboratory, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Division of Respiratory Medicine, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Division of Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Division of Microbiology, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Etsuro Nanishi, Matthew Hwang, Michelle Barton, Upton D Allen

Förderung

  • The Hospital for Sick Children Foundation
  • University of Toronto
  • Canadian Institutes of Health Research

Zitieren

APA

Nanishi, E., Hwang, M., Márquez, A. C., Byrne, W., La Neve, M. R., Litosh, A., Saini, J. S., Thompson, K., Wisener, N., Nanishi, M., Upton, J. E. M., Campigotto, A., Barton, M., Jassem, A. N., & Allen, U. D. (2026). Preexisting Humoral Immunity Against Seasonal Coronaviruses Enhances Antibody Responses on SARS-CoV-2 Vaccination. Open Forum Infectious Diseases, 13(5). https://doi.org/10.1093/ofid/ofag232

Vancouver

Nanishi E, Hwang M, Márquez AC, Byrne W, La Neve MR, Litosh A, et al. Preexisting Humoral Immunity Against Seasonal Coronaviruses Enhances Antibody Responses on SARS-CoV-2 Vaccination. Open Forum Infectious Diseases. 2026;13(5). doi:10.1093/ofid/ofag232

BibTeX
@article{Nanishi2026,
  author = {Nanishi, Etsuro and Hwang, Matthew and Márquez, Ana Citlali and Byrne, Walter and La Neve, Maria-Rosa and Litosh, Alice and Saini, Jasmik S and Thompson, Kimberly and Wisener, Nicole and Nanishi, Makiko and Upton, Julia E M and Campigotto, Aaron and Barton, Michelle and Jassem, Agatha N and Allen, Upton D},
  title = {Preexisting Humoral Immunity Against Seasonal Coronaviruses Enhances Antibody Responses on SARS-CoV-2 Vaccination},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {5},
  doi = {10.1093/ofid/ofag232}
}
Kostenlos starten →